Fosaprepitant

Fosaprepitant

Drugbox
IUPAC_name = [3-{ [(2"R",3"S")-2- [(1"R")-1- [3,5-bis(trifluoromethyl)phenyl] ethoxy] -3-(4-fluorophenyl)morpholin-4-yl] methyl}-5-oxo- 2"H"-1,2,4-triazol-1-yl] phosphonic acid



CAS_number = 172673-20-0
CAS_supplemental = CAS|265121-04-8 (dimeglumine)
ATC_prefix = A04
ATC_suffix = AD12
PubChem = 219090
DrugBank =
C=23|H=22|F=7|N=4|O=6|P=1
molecular_weight = 614.406 g/mol
bioavailability = n/a
protein_bound = >95% (aprepitant)
metabolism = To aprepitant
elimination_half-life = 9 to 13 hours (aprepitant)
excretion =
pregnancy_AU =
pregnancy_US = B
pregnancy_category=
legal_AU =
legal_CA =
legal_UK =
legal_US = Rx-only
routes_of_administration = Intravenous
licence_EU =Ivemend
licence_US =Fosaprepitant

Fosaprepitant (INN; trade names Emend for Injection, Ivemend) is an anti-emetic drug, administered intravenously. It is a prodrug of aprepitant.

It was developed by Merck & Co. and was approved by the United States Food and Drug Administration (FDA) on January 25, 2008 . [cite web |url=http://www.drugs.com/newdrugs/fda-approves-emend-fosaprepitant-dimeglumine-merck-s-new-intravenous-therapy-combination-other-833.html |title=Drugs.com, FDA Approves Emend (fosaprepitant dimeglumine) for Injection, Merck's New Intravenous Therapy, for Use in Combination with Other Antiemetics for Prevention of Nausea and Vomiting Caused by Chemotherapy |accessdate=2008-03-15 |format= |work= ] and by the European Medicines Agency (EMA) on January 11 of the same year. [cite web |url=http://www.emea.europa.eu/humandocs/Humans/EPAR/ivemend/ivemend.htm |title=European Public Assessment Report for Ivemend (from the EMEA website) |accessdate=2008-03-15 |format= |work= ]

References


Wikimedia Foundation. 2010.

Игры ⚽ Поможем написать курсовую

Look at other dictionaries:

  • fosaprepitant — noun A prodrug of aprepitant, administered intravenously as an antiemetic …   Wiktionary

  • fosaprepitant dimeglumine — fosa·prep·i·tant di·meg·lu·mine (fos ə prepґĭ tənt) a prodrug of aprepitant that rapidly converts to aprepitant in the body; administered intravenously as an antiemetic …   Medical dictionary

  • NK1 receptor antagonist — Neurokinin 1 (NK1) antagonists are a novel class of medications that possesses unique antidepressant,[1] anxiolytic,[2] and antiemetic properties. The discovery of neurokinin 1 (NK1) receptor antagonists was a turning point in the prevention of… …   Wikipedia

  • Merck & Co. — Merck Co., Inc. (Merck Sharp Dohme (MSD) outside the United States and Canada) Type Public Traded as NYSE:  …   Wikipedia

  • Aprepitant — drugbox IUPAC name = 5 [(2 S ,3 R ) 2 [(1 R ) 1 [3,5 bis(trifluoromethyl)phenyl] ethoxy] 3 (4 fluorophenyl)morpholin 4 yl] methyl] 1,2 dihydro 1,2,4 triazol 3 one CAS number = 170729 80 3 ATC prefix = A04 ATC suffix = AD12 ATC supplemental =… …   Wikipedia

  • Tachykinin peptides — Tachykinin family Structure of the tachykinin peptide Kassinin.[1] Identifiers Symbol Tachy …   Wikipedia

  • Tachykinin receptor 1 — Rendering based on PDB 2KS9 …   Wikipedia

  • Maropitant — Systematic (IUPAC) name (7R,8S) N [(5 tert Butyl 2 methoxyphenyl)methyl] 7 [di(phenyl)methyl] 1 azabicyclo[2.2.2]octan 8 amine Clinical data …   Wikipedia

  • Aprepitant — Strukturformel Allgemeines Freiname Aprepitant Andere Namen …   Deutsch Wikipedia

  • Scopolamine — Systematic (IUPAC) name (–) (S) 3 hydroxy 2 pheny …   Wikipedia

Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”